Arno Therapeutics, Inc. (ARNI)

OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: Jan 30, 2026
Market Cap49.00 -100.0%
Revenue (ttm)n/a
Net Income-13.70M
EPS-0.38
Shares Out49.35M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume1,000
Average Volume7,551
Open0.0000
Previous Closen/a
Day's Range0.0000 - 0.0000
52-Week Range0.0000 - 0.0002
Beta-19.19
RSI38.00
Earnings Daten/a

About Arno Therapeutics

Arno Therapeutics, Inc., a biopharmaceutical company, develops products for the treatment of cancer and other life threatening diseases. The company’s product development pipeline includes Onapristone, a type 1 anti-progestin hormone blocker that is in Phase I/II clinical study for the treatment of breast, endometrial, and others solid tumors in post-menopausal women; and advanced castration-resistant prostate cancer in men. Its product development pipeline also consists of AR-12, an orally available cancer treatment, which has completed Phase ... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2005
Employees 4
Stock Exchange OTCMKTS
Ticker Symbol ARNI
Full Company Profile

Financial Performance

Financial Statements